Dokterspraktijk Marten Geyskens
0826.756.041 · rovalta.com · 27/09/2026
Dokterspraktijk Marten Geyskens
Financial year 2025 · Closed on 30/09/2025
Overview
Identity
Source · BCE/KBODokterspraktijk Marten Geyskens is a Private company with limited liability incorporated in 2010. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Scherpenheuvel-Zichem. It employs on average 2,2 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0826.756.041
- Incorporation
- 14/06/2010
- Legal form
- Private company with limited liability
- Registered office
- Basilieklaan 74
3270 Scherpenheuvel-Zichem · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 30/09/2025
- Average workforce
- 2,2 ETP
Joint committees (1)
- 330
Financials
Source · NBB, 15 filingsTrend over 15 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 744 k € | +4.8% | 710 k € | +17.7% | 603,1 k € | +41.7% | 425,7 k € | +4.6% | 407,2 k € |
| EBITDA | 620,1 k € | +9.8% | 564,8 k € | +22.3% | 461,7 k € | +38.9% | 332,4 k € | -4.5% | 347,9 k € |
| Operating result | 545,7 k € | +6.5% | 512,3 k € | +24.8% | 410,5 k € | +38.3% | 296,8 k € | -7.1% | 319,6 k € |
| Net result | 378,3 k € | +6.9% | 353,9 k € | +19.9% | 295,1 k € | +63.4% | 180,6 k € | -15.4% | 213,6 k € |
| Balance sheet | |||||||||
| Equity | 1,2 M € | -21.1% | 1,5 M € | +29.2% | 1,2 M € | +21.6% | 972 k € | +2.6% | 947 k € |
| Total assets | 2,6 M € | +13.3% | 2,3 M € | +18.3% | 1,9 M € | +13.9% | 1,7 M € | +28.5% | 1,3 M € |
| Cash | 25,2 k € | -84.5% | 162,1 k € | +383% | 33,6 k € | -48.2% | 64,8 k € | -39.8% | 107,7 k € |
| Debts | 1,4 M € | +85.1% | 747,1 k € | -0.2% | 748,5 k € | +3.5% | 723,4 k € | +94.7% | 371,5 k € |
| Other | |||||||||
| Workforce | 2,2 ETP | -15.4% | 2,6 ETP | +4.0% | 2,5 ETP | -10.7% | 2,8 ETP | – | |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/09/20251 active · 3 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Micro model | Micro model |
| Start of the financial year | 01/10/2024 | 01/10/2023 | 01/10/2022 | 01/10/2021 | 01/10/2020 | 01/10/2019 |
| Closing of the financial year | 30/09/2025 | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 | 30/09/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/04/2026 | 30/04/2025 | 30/04/2024 | 28/04/2023 | 06/05/2022 | 13/04/2021 |
| General meeting | 20/02/2026 | 21/02/2025 | 16/02/2024 | 17/02/2023 | 29/04/2022 | 26/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/09/2025 | 20/02/2026 | 30/04/2026 | Dutch | |
| Abridged model | 30/09/2024 | 21/02/2025 | 30/04/2025 | Dutch | |
| Abridged model | 30/09/2023 | 16/02/2024 | 30/04/2024 | Dutch | |
| Abridged model | 30/09/2022 | 17/02/2023 | 28/04/2023 | Dutch | |
| Micro model | 30/09/2021 | 29/04/2022 | 06/05/2022 | Dutch | |
| Micro model | 30/09/2020 | 26/03/2021 | 13/04/2021 | Dutch | |
| Micro model | 30/09/2019 | 31/03/2020 | 05/05/2020 | Dutch | |
| Micro model | 30/09/2018 | 19/03/2019 | 25/03/2019 | Dutch | |
| Micro model | 30/09/2017 | 29/03/2018 | 30/03/2018 | Dutch | |
| Abridged model | 30/09/2016 | 21/03/2017 | 24/03/2017 | Dutch | |
| Abridged model | 30/09/2015 | 29/03/2016 | 24/06/2016 | Dutch | |
| Abridged model | 30/09/2014 | 09/04/2015 | 09/04/2015 | Dutch | |
| Abridged model | 30/09/2013 | 28/04/2014 | 28/04/2014 | Dutch | |
| Abridged model | 30/09/2012 | 30/05/2013 | 30/05/2013 | Dutch | |
| Abridged model | 30/09/2011 | 29/05/2012 | 31/05/2012 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20251 active · 3 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other29/06/2010RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025378,3 k €↑
- 2024Annual accounts 2024353,9 k €↑
- 2023Annual accounts 2023295,1 k €↑
- 2022Annual accounts 2022180,6 k €↓
- 2021Annual accounts 2021213,6 k €↑
- 2020Annual accounts 2020195,5 k €↑
- 2019Annual accounts 2019111,5 k €↑
- 2018Annual accounts 20188,4 k €↓
- 2017Annual accounts 2017115,5 k €↑
- 2016Annual accounts 201643,7 k €↑
- 2015Annual accounts 201513,8 k €↓
- 2014Annual accounts 201454 k €↓
- 2013Annual accounts 201386,9 k €↓
- 2012Annual accounts 2012132,9 k €↓
- 2011Annual accounts 2011146 k €
- 14/06/2010IncorporationPrivate company with limited liability